Chronic Lymphocytic Leukemia Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Ibrutinib
- +3 more
- Birmingham, Alabama
- +866 more
2022-04-07
Apr 7, 2022M
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Houston, TexasM D Anderson Cancer Center
2022-04-07
Apr 7, 2022N
Recruiting
- Chronic Lymphocytic Leukemia
- During Venetoclax
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022A
Recruiting
- Chronic Lymphocytic Leukemia
- Acalabrutinib
- +3 more
- Fountain Valley, California
- +276 more
2022-04-07
Apr 7, 2022N
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Obinutuzumab
- +3 more
- Birmingham, Alabama
- +461 more
2022-04-06
Apr 6, 2022S
Terminated
- Chronic Lymphocytic Leukemia
- +3 more
- TP-0903
- TP-0903 and ibrutinib combination therapy
- Phoenix, Arizona
- +5 more
2022-04-04
Apr 4, 2022N
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Ibrutinib
- +3 more
- Birmingham, Alabama
- +873 more
2022-04-05
Apr 5, 2022O
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- CLIC-1901
- Vancouver, British Columbia, Canada
- +1 more
2022-03-26
Mar 26, 2022N
Active, not recruiting
- Anemia
- +2 more
- Cyclophosphamide
- +6 more
- Birmingham, Alabama
- +795 more
2022-04-05
Apr 5, 2022P
Not yet recruiting
- Chronic Lymphocytic Leukemia
- (no location specified)
2022-04-02
Apr 2, 2022N
Completed
- Chronic Myelogenous Leukemia
- +9 more
- Fludarabine
- +3 more
- Atlanta, GeorgiaNorthside Hospital
2022-04-04
Apr 4, 2022A
Recruiting
- Chronic Lymphocytic Leukemia
- Irkutsk, Russian Federation
- +12 more
2022-03-25
Mar 25, 2022W
Withdrawn
- Chronic Lymphocytic Leukemia
- CLL/SLL
- New York, New YorkWeill Cornell Medicine
2022-03-25
Mar 25, 2022T
Recruiting
- Acute Lymphoblastic Leukemia
- +15 more
- Hematopoietic Cell Transplantation
- +7 more
- Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
2022-04-01
Apr 1, 2022U
Recruiting
- Chronic Lymphocytic Leukemia
- +4 more
- Bobigny, France
- +8 more
2022-03-23
Mar 23, 2022N
Recruiting
- Waldenstrom Macroglobulinemia
- +4 more
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2022-03-31
Mar 31, 2022A
Recruiting
- Chronic Lymphocytic Leukemia
- Irkutsk, Russian Federation
- +5 more
2022-03-30
Mar 30, 2022I
Recruiting
- Chronic Lymphocytic Leukemia
- Non Hodgkin Lymphoma
- Birmingham, Alabama
- +48 more
2022-03-30
Mar 30, 2022K
Recruiting
- Diffuse Large B Cell Lymphoma
- +2 more
- Goshen, Indiana
- +39 more
2022-03-28
Mar 28, 2022I
Not yet recruiting
- Chronic Lymphocytic Leukemia
- +2 more
- Zanubrutinib, Fludarabine, cyclophosphamide and rituximab
- Zanubrutinib, bendamustine, rituximab
- Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
2022-03-18
Mar 18, 2022W
Recruiting
- Chronic Lymphocytic Leukemia
- +2 more
- New York, New YorkWeill Cornell Medicine
2022-03-29
Mar 29, 2022A
Recruiting
- Chronic Lymphocytic Leukemia
- +2 more
- Phoenix, Arizona
- +30 more
2022-03-28
Mar 28, 2022M
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +5 more
- Ibrutinib
- +2 more
- Houston, TexasM D Anderson Cancer Center
2022-03-15
Mar 15, 2022B
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- ICP-022
- +2 more
- Bengbu, Anhui, China
- +55 more
2022-03-25
Mar 25, 2022U
Withdrawn
- Acute Lymphoblastic Leukemia
- +2 more
- PACE CART19
- (no location specified)
2022-03-09
Mar 9, 2022